April 2017: Amgen (Stock to Study), Qualcomm (Undervalued)The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Amgen Inc. (NDQ: AMGN) as its April 2017 "Stock to Study" and Qualcomm Incorporated (NDQ: QCOM) as its April 2017 "Undervalued Stock" for investors' informational and educational use.
"The committee selected Amgen for the company's history of growth coupled with potential easing of regulations and a reasonable current valuation," said Adam Ritt, editor of BetterInvesting Magazine. "For the Undervalued selection, the committee cited Qualcomm's strong market position, potential for improved fundamentals and reasonable P/E."
Check BetterInvesting's April issue for more details about these selections. Go to the trial version of BetterInvesting's online tools to study the investment potential of Amgen and Qualcomm by viewing their fundamental data and applying judgments.
Committee members are Robert M. Bilkie, Jr., CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip S. Dano, CFA; Donald E. Danko, CFA; Maury Elvekrog, CFA; and Walter J. Kirchberger, CFA.
As stated, the BetterInvesting committee's Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors and are not intended as investment recommendations. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.